Hackman Jeffrey S.
SEC CIK 1926254 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FENC | FENNEC PHARMACEUTICALS INC. | CEO, Dir | 66.3K | $104.6K | — | 8 | 2025-05-16 | 2026-08-31 |
Most active insiders at FENC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Southpoint Capital Advisors LP | 10% | — | $7.50M |
| 2 | Southpoint GP, LLC | 10% | — | $2.04M |
| 3 | Raykov Rosty | Former Dir | — | $1.05M |
| 4 | Andrade Robert | CFO | — | $883.5K |
| 5 | Southpoint Capital Advisors LLC | 10% | — | $806.3K |
| 6 | Brughera Marco Maria | Dir | — | $160.0K |
| 7 | Sayad Pierre Sargis | Chief Medical Off | — | $146.2K |
| 8 | RALLIS CHRIS A | Dir | — | $75.2K |
| 9 | Cioffi Christiana Marie | Chief Strategy Off | — | — |
| 10 | Evans Terry L | Chief Commercial Off | — | — |
| 11 | Hackman Jeffrey S. | CEO, Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-31 20:10 | 2026-08-31 | FENC | FENNEC PHARMACEUTICALS INC. | Hackman Jeffrey S. | CEO, Dir | A - Grant | $0.00 | +1,159 | 66.3K | +2% | $0 | |
| 2026-08-03 16:05 | 2026-07-31 | FENC | FENNEC PHARMACEUTICALS INC. | Hackman Jeffrey S. | CEO, Dir | A - Grant | $0.00 | +1,159 | 65.1K | +2% | $0 | |
| 2026-07-01 16:36 | 2026-06-30 | FENC | FENNEC PHARMACEUTICALS INC. | Hackman Jeffrey S. | CEO, Dir | A - Grant | $0.00 | +1,159 | 64.0K | +2% | $0 | |
| 2026-06-01 16:05 | 2026-05-31 | FENC | FENNEC PHARMACEUTICALS INC. | Hackman Jeffrey S. | CEO, Dir | A - Grant | $0.00 | +1,159 | 62.8K | +2% | $0 | |
| 2026-05-01 16:05 | 2026-04-30 | FENC | FENNEC PHARMACEUTICALS INC. | Hackman Jeffrey S. | CEO, Dir | M - OptEx | $0.00 | +1,159 | 61.7K | +2% | $0 | |
| DM | 2026-04-02 16:05 | 2026-03-28+ | FENC | FENNEC PHARMACEUTICALS INC. | Hackman Jeffrey S. | CEO, Dir | M - OptEx | $0.00 | +31.8K | 60.5K | +111% | $0 |
| 2026-02-19 | 2026-02-18 | FENC | FENNEC PHARMACEUTICALS INC. | Hackman Jeffrey S. | CEO, Dir | M - OptEx | $0.00 | +13.7K | 28.7K | +91% | $0 | |
| M | 2025-05-19 | 2025-05-16+ | FENC | FENNEC PHARMACEUTICALS INC. | Hackman Jeffrey S. | CEO, Dir | P - Purchase | $6.97 | +15.0K | 15.0K | New | +$104.6K |
Purchase Sale Sale after option exercise All abbreviations